Faricimab news

All news on Faricimab (also known as Vabysmo): plants, production capacities, investments and involved companies.

17 October 2025
Roche Unveils Phase III Data for Vamikibart in Uveitic Macular Edema
Vamikibart shows promise in treating UME, with significant vision improvements in trials, offering a non-steroid alternative with fewer side effects.

Who will be producing Faricimab in the future?

Find out with chemXplore Analytics